January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Why Dana-Farber Direct Connect? – Dana-Farber Cancer Institute
Jan 15, 2025, 11:08

Why Dana-Farber Direct Connect? – Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared a post on LinkedIn:

“When it comes to cancer treatment, where you begin can make all the difference. The Dana-Farber Direct Connect program provides partnering organizations with streamlined access to the world-renowned cancer expertise at Dana-Farber Cancer Institute.

Why Dana-Farber Direct Connect?

Access to Expertise: Connect your employees and their families with some of the world’s leading cancer specialists, renowned for their groundbreaking research and treatment approaches.

Personalized Guidance: Our dedicated patient liaisons provide a seamless and supportive experience, ensuring that each individual receives the attention and care they deserve.

Customized Care: Dana-Farber offers tailored treatment plans that address the specific type of cancer, leveraging the latest advancements in oncology to optimize outcomes.

By partnering with Dana-Farber Direct Connect, you are making a profound investment in the health and well-being of your workforce. Empower your employees and their families with the best possible start in their cancer treatment journey.

Join our open webinar on Thursday, January 16th 1pm ET to learn more about how Dana-Farber Direct Connect can benefit your organization.”

Why Dana-Farber Direct Connect? - Dana-Farber Cancer Institute

Dana-Farber Cancer Institute, located in Boston, Massachusetts, is a leading institution for cancer treatment and research. It was founded by Sidney Farber on 1947. Currently, the Institute has over 5,000 staff, faculty, and clinicians on board. They manage in excess of 640,000 outpatient visits each year, oversee more than 1,000 hospital discharges annually, and are actively involved in over 1,100 ongoing clinical trials.As of 2023, Dana-Farber is ranked as the #4 cancer hospital globally. Dana-Farber’s research contributions include the development of Gleevec, a highly successful treatment for chronic myeloid leukemia.